Recent clinical studies conducted by the World Health Organization, Johns Hopkins and the US Navy/Walter Reed Institute of Research (WRAIR) compared use of CeraVacx to commercially available buffers and found that CeraVacx:

• Increases protection of vaccines and drugs from stomach acid
• Accelerates delivery of the vaccine or drug
• Significantly boosts the immune response

The buffer salts in CeraVacx’s base neutralize stomach acid, and the long-chain carbohydrates promote rapid and sustained absorption. Potential applications in human and animal health include:

• Oral vaccines (e.g., cholera, E. Coli, rotavirus, and others)
• Effective delivery of acid-sensitive drugs and peptides
• Development of probiotics and other biologicals
• Improvement of heat stability of vaccines.

For nutritional information, click here.

CeraLyte | CeraSport | CeraVet |CeraFlu^TM